Efficacy and safety of ponatinib in chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) patients in real-world clinical practice: data from a Belgian registry 

0 views
0 downloads

Powered byMorressier logo black

Discover more research and events on morressier.com